CLOV vs GDRX · rev $1.37B vs P/E 49, rev $796.9M
Clover Health Investments Corp (CLOV) versus Goodrx Holdings Inc (GDRX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Goodrx Holdings Inc (GDRX) is a health information services company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported GDRX revenue for 2025-12-31 was $796.9M. Net income was $30.4M. Revenue was up 0.6% from 2024-12-31 to 2025-12-31. GDRX currently screens at market cap $988.9M and trailing P/E 48.7.
CLOV currently screens at market cap $1.55B. GDRX currently screens at market cap $988.9M and trailing P/E 48.7.
Not investment advice. Open the CLOV and GDRX stock pages for the full models.
Not investment advice.